Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
Steven J Ryder,1 Danilo Iannetta,1 Swetangi D Bhaleeya,2 Szilárd Kiss1 1Department of Ophthalmology, Weill Cornell Medical College, New York, NY, USA; 2Department of Ophthalmology, University of South Florida, Tampa, FL, USA Purpose: To report our experience with bilateral placement of...
Guardado en:
Autores principales: | Ryder SJ, Iannetta D, Bhaleeya SD, Kiss S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/033d297b5fb74a07ab13a9dc23dff09f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Jane S Myung, et al.
Publicado: (2010) -
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail A, et al.
Publicado: (2018) -
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter RS, et al.
Publicado: (2011) -
Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan HY, et al.
Publicado: (2016) -
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
por: Sheppard Jr JD, et al.
Publicado: (2012)